TTIP: No Lowering Of Standards, Officials Say; New Trade Consultation Body Scrutinised 20/02/2014 by Monika Ermert for Intellectual Property Watch Leave a Comment After three rounds of negotiations for the Transatlantic Trade and Investment Partnership (TTIP), European Union Trade Commissioner Karel de Gucht this week welcomed the progress so far. But negotiators have to “step up a gear,” de Gucht said after a two-day stocktaking meeting with the United States Trade Representative Michael Froman in Washington, DC on 18 February. Meanwhile, USTR announced new steps to raise public participation in trade negotiations.
South African Traditional Knowledge Protection Bill Amends IP Laws 19/02/2014 by Linda Daniels for Intellectual Property Watch 1 Comment The much-debated Intellectual Property Laws Amendment Bill in South Africa, aimed at boosting protection for traditional knowledge, was signed by President Jacob Zuma without much fanfare and promotion. What happens now?
3D Printing Will Cost The World USD100 Billion, Says Study 19/02/2014 by Julia Fraser for Intellectual Property Watch 1 Comment A recent report predicts the loss of at least $100 billion per year in intellectual property globally by 2018 as a result of 3D printing.
European Parliament Key Vote On Net Neutrality Laws – 24 February 19/02/2014 by Intellectual Property Watch Leave a Comment The European Parliament (EP) is scheduled to vote on 24 February on the draft Single Telecoms Package Regulation drafted by the Industry, Research and Energy Committee – on the future of neutral internet.
Infojustice.org: Australia Commits To Overhaul Of Copyright Act 18/02/2014 by Intellectual Property Watch Leave a Comment From infojustice.org: [Australian Digital Alliance] It has been a big week for Australian Copyright. On Thursday the Attorney-General, the Hon George Brandis QC, tabled the long-anticipated final report from the Australian Law Reform Commission’s (ALRC) Copyright and the Digital Economy inquiry. This inquiry was charged with determining if copyright exceptions and limitations were working in the digital age. The conclusion was that reform was needed.
Battles Over Patents: Is India Changing The Rules Of The Game? 18/02/2014 by Ranjitha Balasubramanyam for Intellectual Property Watch 4 Comments Over the last couple of years, news of pharmaceutical patents and India’s attempts to protect and manage its market has caught the attention of intellectual property observers everywhere and the pharmaceutical industry in particular.
Paper Makes Recommendations For Exhaustion Of IP Rights 17/02/2014 by Julia Fraser for Intellectual Property Watch 1 Comment A recent paper issued by the International Centre for Trade and Sustainable Development (ICTSD) compares existing exhaustion policies and makes recommendations for countries in the process of adopting their own regimes in this area. These have the potential to contribute to economic and social development, innovation and the protection of user rights globally, it said.
Seminar Shows Continued Divergence Among Nations On Regulating Internet 14/02/2014 by Maëli Astruc for Intellectual Property Watch 1 Comment It is generally considered that internet governance and cyber safety issues should be addressed in a multilateral way, but several points remain highly controversial, such as the adoption of rules and modifications of internet governance to be made. These issues were the subject of a panel at the UN Institute for Disarmament Research this week.
South Africa Promotion And Protection Of Investment Bill 2013 – A Review 13/02/2014 by Intellectual Property Watch 2 Comments On 1 November 2013, the South African Department of Trade and Industry published the draft “Promotion and Protection of Investment Bill” for comments. And two lawyers caution that if not careful, it could come in conflict with the country’s international intellectual property obligations.
Biopharma Industries, Others Urge Caution In US Patent Reform 12/02/2014 by William New, Intellectual Property Watch Leave a Comment A coalition of large and small companies and organisation – including the leading trade associations for the US pharmaceutical and biotechnology industries – has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.